Vito Baraka(PhD)
TitleCited byYear
Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children
T Lavstsen, L Turner, F Saguti, P Magistrado, TS Rask, JS Jespersen, ...
Proceedings of the National Academy of Sciences 109 (26), E1791-E1800, 2012
2172012
Genomic epidemiology of artemisinin resistant malaria
MalariaGEN Plasmodium falciparum Community Project
elife 5, e08714, 2016
1162016
In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso
V Baraka, H Tinto, I Valea, R Fitzhenry, C Delgado-Ratto, MK Mbonye, ...
Antimicrobial agents and chemotherapy 59 (1), 734-737, 2015
272015
High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania
V Baraka, DS Ishengoma, F Fransis, DTR Minja, RA Madebe, D Ngatunga, ...
Malaria journal 14 (1), 439, 2015
212015
Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate–amodiaquine in Africa
LC Okell, LM Reiter, LS Ebbe, V Baraka, D Bisanzio, OJ Watson, ...
BMJ global health 3 (5), e000999, 2018
142018
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of …
HM Mavoko, C Nabasumba, RI da Luz, H Tinto, U D'Alessandro, ...
The Lancet Global Health 5 (1), e60-e68, 2017
102017
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 …
V Baraka, HM Mavoko, C Nabasumba, F Francis, P Lutumba, M Alifrangis, ...
PLoS One 13 (2), e0191922, 2018
82018
The role of malaria rapid diagnostic tests in screening of patients to be enrolled in clinical trials in low malaria transmission settings
DS Ishengoma, A Shayo, CI Mandara, V Baraka, RA Madebe, ...
Health Syst Policy Res 3 (2), 2016
82016
Genomic epidemiology of artemisinin resistant malaria.
A Amato, O Miotto, CJ Woodrow, J Almagro-Garcia, I Sinha, S Campino, ...
82016
Habitat productivity and pyrethroid susceptibility status of Aedes aegypti mosquitoes in Dar es Salaam, Tanzania
L Mathias, V Baraka, A Philbert, E Innocent, F Francis, G Nkwengulila, ...
Infectious diseases of poverty 6 (1), 102, 2017
72017
Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo
V Baraka, C Delgado-Ratto, S Nag, DS Ishengoma, RA Madebe, ...
International journal of antimicrobial agents 49 (4), 456-464, 2017
72017
The threat of Zika virus in sub-Saharan Africa–the need to remain vigilant
V Baraka, EJ Kweka
Frontiers in public health 4, 110, 2016
62016
Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
L Golassa, E Kamugisha, DS Ishengoma, V Baraka, A Shayo, ...
Malaria journal 14 (1), 264, 2015
62015
The readiness of the national health laboratory system in supporting care and treatment of HIV/AIDS in Tanzania
LEG Mboera, DS Ishengoma, AM Kilale, IS Massawe, ASM Rutta, ...
BMC health services research 15 (1), 248, 2015
52015
Risks of hemolysis in glucose-6-phosphate dehydrogenase deficient infants exposed to chlorproguanil-dapsone, mefloquine and sulfadoxine-pyrimethamine as part of intermittent …
E Poirot, E Vittinghoff, D Ishengoma, M Alifrangis, I Carneiro, R Hashim, ...
PloS one 10 (11), 2015
32015
Performance of health laboratories in provision of HIV diagnostic and supportive services in selected districts of Tanzania
DS Ishengoma, ML Kamugisha, ASM Rutta, GB Kagaruki, AM Kilale, ...
BMC health services research 17 (1), 70, 2017
12017
Usefulness of day 7 lumefantrine plasma concentration as a predictor of malaria treatment outcome in under-fives children treated with artemether-lumefantrine in Tanzania
M Kilonzi, O Minzi, R Mutagonda, V Baraka, P Sasi, E Aklillu, ...
Malaria Journal 19 (1), 1-8, 2020
2020
Effectiveness and safety of intermittent preventive treatment for malaria using either dihydroartemisinin-piperaquine or artesunate-amodiaquine in reducing malaria related …
G Makenga, V Baraka, F Francis, S Nakato, S Gesase, G Mtove, ...
Contemporary Clinical Trials Communications, 100546, 2020
2020
EPIDEMIOLOGY OF MALARIA AND ANAEMIA AMONG SCHOOL AGED CHILDREN IN TANZANIA: P061
G Makenga, V Baraka, D Minja, S Nakato, F Francis, R Madebe, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 113, 2019
2019
PREVALENCE OF MALARIA PARASITAEMIA IN PREGNANT WOMEN AND SCHOOL AGED CHILDREN LIVING IN SIMILAR ENDEMIC SETTING OF SUB SAHARAN AFRICA: A SYSTEMATIC REVIEW AND META-ANALYSIS: P062
G Makenga, S Menon, V Baraka, D Minja, S Nakato, F Francis, J Lusingu
Transactions of the Royal Society of Tropical Medicine and Hygiene 113, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20